Cargando…
A clinical pharmacology study of the novel, selective urate reabsorption inhibitor dotinurad in outpatients
BACKGROUND: Dotinurad is a novel, selective urate reabsorption inhibitor (SURI), which reduces serum uric acid levels by selective inhibition of the urate transporter 1 (URAT1). The Japanese guideline for the management of hyperuricemia and gout recommends that drug selection should be based on clas...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066296/ https://www.ncbi.nlm.nih.gov/pubmed/32067130 http://dx.doi.org/10.1007/s10157-020-01857-0 |